Suppressive effects of 17&beta;-estradiol on hepatic fibrosis in CCl4-induced rat model

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 9

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

359

HTML

2129

Figures (1-7)

149

Tables (1-1)

139

Sum=2776

May 1, 2004 (publication date) through Jul 27, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Research

World J Gastroenterol. May 1, 2004; 10(9): 1315-1320
Published online May 1, 2004. doi: 10.3748/wjg.v10.i9.1315

Full Size Figure Download Figure

Figure 4 Serum estradiol levels in CCl₄–treated female rats, ^bP<0. 01 vs control, ^dP<0.01 vs CCl₄.

Citation: Liu QH, Li DG, Huang X, Zong CH, Xu QF, Lu HM. Suppressive effects of 17β-estradiol on hepatic fibrosis in CCl₄-induced rat model. World J Gastroenterol 2004; 10(9): 1315-1320
URL: https://www.wjgnet.com/1007-9327/full/v10/i9/1315.htm
DOI: https://dx.doi.org/10.3748/wjg.v10.i9.1315